News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Gilead Sciences, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Biotech Bay
Why Gilead Could Be a Gold Mine for Value Investors
April 17, 2017
·
1 min read
Deals
What Happens if Gilead Went Bigger Than Incyte and Made a Play for This Pharma Giant
April 10, 2017
·
2 min read
FDA
Gilead Release: FDA Approves New Indications For Harvoni And Sovaldi In Pediatric Patients 12 Years And Older With Chronic Hepatitis C Infection
April 7, 2017
·
10 min read
Job Trends
Gilead Quietly Starts Recruiting Employees for China Expansion
April 7, 2017
·
3 min read
Business
Ex-Gilead Director Founded and Will Helm Bay Area Cancer Startup Apostle
April 3, 2017
·
3 min read
Biotech Bay
Has Gilead Lost Its Way?
March 31, 2017
·
1 min read
Drug Development
How This Drug Candidate Could be a Winner in Gilead’s Pipeline
March 21, 2017
·
3 min read
BioMidwest
4 Small-Cap Biotechs to Consider if Gilead Isn’t Doing it For You
March 21, 2017
·
2 min read
Biotech Bay
3 Numbers That Make Gilead Look Cheaper Than It Really Is
March 17, 2017
·
1 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Repare Therapeutics Announces Acquisition of Polθ ATPase Inhibitor, RP-3467, by Gilead Sciences for Up To $30 Million in Total Consideration
December 25, 2025
·
8 min read
Press Releases
Gilead Sciences to Present at Upcoming Investor Conference
December 23, 2025
·
1 min read
Press Releases
Gilead Sciences Exercises Option to License Assembly Biosciences’ Helicase-Primase Inhibitor Programs for Recurrent Genital Herpes
December 23, 2025
·
8 min read
Press Releases
Faron Announces Strategic Collaboration with The Institute for Cancer Research to Launch BLAZE Trial, Targeting Immunotherapy Resistance in Cancer
December 22, 2025
·
5 min read
Press Releases
Gilead and U.S. Government Enter Agreement to Lower Costs of Medicines for Americans
December 22, 2025
·
5 min read
Press Releases
Gilead Sciences Appoints Keeley Wettan as Executive Vice President, General Counsel, Legal & Compliance
December 19, 2025
·
2 min read
Press Releases
Gilead’s Investigational Single-Tablet Regimen of Bictegravir and Lenacapavir for HIV Treatment Meets Primary Endpoint in Phase 3 ARTISTRY-2 Trial
December 16, 2025
·
9 min read
Press Releases
Arcus Provides Update on Phase 3 STAR-221 Study and Concentrates Its R&D Investment on Casdatifan and Emerging Inflammation and Immunology Portfolio
December 15, 2025
·
13 min read
Press Releases
Gilead Foundation Awards Over $3 Million to Support People Living With Metastatic Breast Cancer
December 10, 2025
·
4 min read
Press Releases
Assembly Biosciences Reports Positive Interim Results from Phase 1b Clinical Studies of Long-Acting Helicase-Primase Inhibitor Candidates ABI-1179 and ABI-5366 Showing Reductions in Viral Shedding Rate and Virologically Confirmed Genital Lesion Rate in Recurrent Genital Herpes
December 9, 2025
·
19 min read
